Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation.

ABSTRACT:

SUBMITTER: Jentzsch M 

PROVIDER: S-EPMC8084997 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature